Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality
Menée in vitro et in vivo, cette étude met en évidence un mécanisme par lequel la protéolyse impliquant la protéase mitochondriale caséinolytique P induit sélectivement la mort des cellules cancéreuses
The mitochondrial caseinolytic protease P (ClpP) plays a central role in mitochondrial protein quality control by degrading misfolded proteins. Using genetic and chemical approaches, we showed that hyperactivation of the protease selectively kills cancer cells, independently of p53 status, by selective degradation of its respiratory chain protein substrates and disrupts mitochondrial structure and function, while it does not affect non-malignant cells. We identified imipridones as potent activators of ClpP. Through biochemical studies and crystallography, we show that imipridones bind ClpP non-covalently and induce proteolysis by diverse structural changes. Imipridones are presently in clinical trials. Our findings suggest a general concept of inducing cancer cell lethality through activation of mitochondrial proteolysis.